If youre concerned about bone health, discuss your concerns with your healthcare provider before using a GLP-1 medication
What forms the bulk of the retail price2 of peptides is not the cost of manufacturing, but the capital infrastructure: the regulatory burden, the cold chain logistics, the pen device (which sometimes costs more than the drug itself), and, above all, the return needed to justify $9 billion in the initial R&D of these GLP-1 drugs
Additional uncertainty comes from the possibility of new therapies or weight-management innovations entering the market, as well as the potential for longer-term side effects that have not yet emerged in real-world populations
This just adds to thoughts that GLPs have anti inflammatory effects which go beyond the weight loss
The emerging opportunity The GLP-1 revolution is creating a new category of skincare consumer: someone who is healthy, weight-optimized, and looking for solutions to a skin quality problem that did not exist before the medication changed their body composition
The problem arises when this antioxidant defense is overwhelmed or depleted: *Excess HO damages thyroid follicular cells, triggering inflammation and immune activation *Oxidized thyroid proteins become neoantigens - foreign-looking molecules that the immune system attacks, initiating or amplifying autoimmune thyroid disease *Lipid peroxidation in thyroid cell membranes disrupts hormone synthesis and cellular integrity *Chronic oxidative stress accelerates thyroid cell apoptosis and fibrosis - the hallmarks of Hashimoto's progression A landmark review published in Antioxidants (MDPI, 2021) - "The Influence of Oxidative Stress on Thyroid Diseases" - confirmed that decreased glutathione levels appear to be a distinctive parameter related to the activation and development of oxidative stress in Hashimoto's thyroiditis, and that antioxidant interventions represent a promising therapeutic avenue for autoimmune thyroid conditions
